Navigation Links
R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany

R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany -- BERLIN, November 3, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Medical Pharmaceuticals, Economic News, Trends, Analysis Click to view news release full screen  

R&D and Demand Draw Medical Biotech Companies and Device Makers to Germany


BERLIN, November 3, 2010 /PRNewswire/ -- Demand for medical biotechnology in Germany grew in 2009, further proving that the economic crisis has been well managed by Europe's largest economy. Revenue in medical biotechnology has increased for a fifth consecutive year, coming in at over EUR 5.7 billion in 2009. This coincides with strong innovation, as hundreds of projects have been realized thanks to cooperation with R&D institutes in Germany. Germany Trade & Invest will have representatives on hand at this year's Open Innovation - Global Strategies in R&D conference on November 4-5 in Boston to share opportunities for American companies in Germany's medical biotechnology and medical device industries.

The importance of R&D for the future of these industries is confirmed by generous funding. At almost EUR 1 billion in 2009, research funding for medical technology remained constant despite the economic downturn. Companies active in the so-called red biotechnology segment are already utilizing Germany's innovative R&D infrastructure, with over 800 cooperation projects with R&D institutes in Germany reported last year. This network of partners facilitates innovation across the entire value chain. Cooperation with other companies, research institutions, and organizations is common, especially for small companies.

Over three quarters of German biotech companies have less than 30 employees. This industry structure allows for international companies of all sizes to easily enter the largest and strongest market in Europe and serve growing demand. Germany's infrastructure, ranked first worldwide by a 2010 World Bank study, enables companies to effectively serve the single European market from Germany.

With over 11,000 companies and 170,000 employees in the medical device industry and several hundred companies working in medical biotechnology, these healthcare industry segments are essential innovation drivers for Germany. Germany is Europe's patent leader with twice the share of registered patents as France and the UK combined. In 2009 German companies were granted over 11,000 patents at the European patent office.

Germany Trade & Invest representatives will be at this year's Open Innovation - Global Strategies in R&D conference in Boston, Massachusetts on November 4-5, 2010. Matchmaking with medical biotechnology and medical device companies will take place with the support of local partners Massachusetts Biotechnology Council (MassBio), Massachusetts Medical Device Industry Council (MassMedic), Massachusetts Life Sciences Center, and the Massachusetts Office of International Trade & Investment (MOITI). Partners from the regional economic development agencies of the federal states of Berlin (Berlin Partner), Mecklenburg-Vorpommern (Invest in Mecklenburg-Vorpommern), and Saxony-Anhalt (IMG Sachsen-Anhalt) will also highlight opportunities in these innovative regions in Eastern Germany.

Germany Trade & Invest is the foreign trade and inward investment promotion agency of the Federal Republic of Germany. The organization advises foreign companies looking to expand their business activities in the German market. It provides information on foreign trade to German companies that seek to enter foreign markets.

Germany Trade & Invest Robert Scheid Email: T: +49(0)30-200099-170 F: +49(0)30-200099-111

SOURCE Germany Trade and Invest
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Biobanking for Medical R&D: Technology and Market 2010-2025
2. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
3. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
4. RIKEN Center for Genomics Medicine Chooses Genedata Expressionist for High Throughput Proteomics R&D
5. US Nanotechnology Instrument Manufacturer Proves the Success of R&D Stimulus
6. Beike Biotechnology, Jiangsu University and Nanjing Drum Tower Hospital Receive $1.8 Million for Human Mesenchymal Stem Cell R&D and Clinical Trials
7. Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
8. Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery
9. UMass Boston Opens Venture Development Center to Expand R&D Activity
10. Reportlinker Adds Downstream Processing in Biopharmaceuticals - Increased Demand for Biologics Drives Improvement in Cost -effective Purification Technologies
11. In-demand Contemporary Research Reports on Biotechnology Markets Available at
Post Your Comments:
(Date:11/30/2015)... and PETACH TIKVAH, Israel , Nov. 30, ... BCLI ), a leading developer of adult stem cell technologies ... Cell Therapeutics Ltd., has been awarded an additional grant of ... the Chief Scientist (OCS). This grant, the second this year, ... activities to approximately $1.8 million (approximately NIS7 million).  ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... Technical Program that includes over 2,000 technical presentations offered in symposia, oral ... chemistry and applied spectroscopy, covers a wide range of applications such as, but ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... 2 nouvelles études permettent d , ... les souches bactériennes retrouvées dans la plaque dentaire ... . Ces recherches  ouvrent une nouvelle voie ... de l,un des problèmes de santé les plus ... --> 2 nouvelles études permettent d , ...
Breaking Biology Technology:
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... OXFORD, Connecticut , October 29, 2015 /PRNewswire/ ... "Company"), a biometric authentication company focused on the ... Wocket® smart wallet announces that StackCommerce, a leading ... will be featuring the Wocket® smart wallet on ... NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:10/27/2015)... Oct. 27, 2015 Synaptics Inc. (NASDAQ: SYNA ... that Google has adopted the Synaptics ® ClearPad ... to power its newest flagship smartphones, the Nexus 5X ... --> --> Synaptics ... provide strategic collaboration in the joint development of next ...
Breaking Biology News(10 mins):